Two New Clinical Studies Show Masimo Noninvasive Hemoglobin Demonstrated Similar Precision As Hemoglobin From Point Of Care Devices

By: via Benzinga
Masimo (NASDAQ: MASI) announced two new studies today that showed that noninvasive hemoglobin (SpHb®) demonstrated similar accuracy as ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.